Collegium Pharmaceutical share price logo

Collegium Pharmaceutical

NASDAQ: COLL

Small Cap

$28.07

-0.16

(-0.57%)

as on

Collegium Pharmaceutical Stock Performance

as on August 18, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $27.87
    $29.01
    downward going graph

    0.71%

    Downside

    3.35%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $25.47
    $50.79
    downward going graph

    9.26%

    Downside

    80.93%

    Upside

    downward going graph

Collegium Pharmaceutical share price movements today

Previous Close
$28.23
Open
$28.37
Volume
787.8K
Market Cap
$875.1M
Day's Low - High
$27.87 - $29.01
52 Week Low - High
$25.47 - $50.79

Collegium Pharmaceutical Historical Returns

1 Month Return
-21.76 %
3 Month Return
-16.43 %
1 Year Return
-25.2 %
3 Year Return
+ 20.64 %
5 Year Return
+ 37.57 %

Collegium Pharmaceutical Stock Fundamentals & Key Indicators

Check Collegium Pharmaceutical market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$875.1M

EPS (TTM)

1.53

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.47%

PE Ratio (TTM)

18.4

Industry PE ratio

3.5878260869565217

PEG Ratio

0.6202987861811384

EBITDA

586.6M

Revenue (TTM)

808.2M

Profit Margin

60.02%

Return On Equity TTM

15.96%

Collegium Pharmaceutical Stock Valuation

Track how Collegium Pharmaceutical P/E has moved over time to understand its valuation trends.

Collegium Pharmaceutical in the last 5 years

  • Overview

  • Trends

Lowest (-31.39x)

December 31, 2022

Industry (3.59x)

December 31, 2025

Today (23.38x)

December 31, 2025

Highest (23.38x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: 23.38x

Collegium Pharmaceutical vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Collegium Pharmaceutical with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$875.1M37.57%18.460.02%NA
BUY$21.4B145.28%16.5886.14%NA
HOLD$18.6B9.88%-44.5634.83%2.9899999999999998%
BUY$42.7BNA19.814.55%126.42999999999999%
BUY$30.5B-64.28%12.4770.87%2.76%

Stock Returns calculator for Collegium Pharmaceutical Stock including INR - Dollar returns

The Collegium Pharmaceutical stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Collegium Pharmaceutical investment value today

Current value as on today

₹81,432

Returns

-₹18,568

(-18.57%)

Returns from Collegium Pharmaceutical Stock

-₹25,623 (-25.62%)

Dollar Impact

₹7,054 (+7.05%)

Analyst Recommendation on Collegium Pharmaceutical Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for Collegium Pharmaceutical. Average target price of $51.2

Collegium Pharmaceutical Share Price Target

Get share price movements and forecasts by analysts on Collegium Pharmaceutical.

What analysts predicted

45.18%UPSIDE

Target Price

$51.2

Current Price

$28.07

Analyzed by

5 Analysts

Target

$51.20

Collegium Pharmaceutical target price $51.2, a slight upside of 45.18% compared to current price of $28.07. According to 5 analysts rating.

Indian Investors' Interest in Collegium Pharmaceutical Stock

Search interest for Collegium Pharmaceutical Stock has increased by 36% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:36% versus previous 30 day period

Collegium Pharmaceutical Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
144
145
159
181
177
188
209
205
193
199
Gross Profit
91
90
96
98
97
108
129
128
117
110
Operating Income
49
47
34
38
21
35
63
59
31
3
EBITDA
89
80
75
96
80
94
121
303
90
70
Interest Expense
17
15
18
22
20
20
21
104
15
19
Depreciation
35
35
41
56
56
56
56
169
55
64
Income Before Tax
36
29
15
17
3
17
43
29
18
-13
Income Tax Expense
8
9
6
4
0
5
11
12
4
1
Net Income
27
19
9
12
2
11
31
16
14
-15
Net Profit Margin
63.11%
62.51%
60.76%
54.02%
54.75%
57.65%
61.70%
62.49%
60.59%
55.18%

Collegium Pharmaceutical Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
28
280
296
310
276
463
566
631
780
Gross Profit
25
114
103
179
150
209
326
377
463
Operating Income
-75
-20
-23
56
17
33
166
169
187
EBITDA
-74
91
-6
118
86
173
308
341
401
Interest Expense
-
20
0
28
21
63
83
73
82
Depreciation
0
110
15
61
68
138
149
169
226
Income Before Tax
-74
-39
-22
27
-3
-28
75
98
92
Income Tax Expense
-
-
-
0
-74
-3
27
29
29
Net Income
-74
-39
-22
26
71
-25
48
69
62
Net Profit Margin
90.89%
40.92%
34.73%
58.01%
54.40%
45.15%
57.55%
59.76%
59.35%

Collegium Pharmaceutical Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
27
19
9
12
2
11
31
16
14
-15
Operating Cash Flow
61
67
-8
84
55
72
78
123
57
71
Investing Cash Flow
-18
-8
-248
-11
-9
-2
-30
-20
1
-502
Financing Cash Flow
-54
-114
149
-41
-25
-48
-14
-21
-21
292
Change in Cash
-10
-55
-108
31
20
21
32
81
37
-139

Collegium Pharmaceutical Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-74
-39
-22
26
71
-25
48
69
62
Operating Cash Flow
-67
169
27
93
103
124
274
204
329
Investing Cash Flow
0
-24
-6
-373
-1
-573
-70
-287
-63
Financing Cash Flow
33
-117
2
286
-89
436
-140
-60
-110
Change in Cash
-34
27
23
6
12
-12
63
-143
155

Mutual Funds that own Collegium Pharmaceutical Stock

Check out the Mutual Funds with significant holdings in Collegium Pharmaceutical.

Funds
Holdings
Shares Held
Capitol Series Trust
4.394658%
1430708
MUTUAL FUND SERIES TRUST
4.325014%
1408035
VANGUARD INDEX FUNDS
3.998192%
1301636
MFS SERIES TRUST I
1.655459%
538945
Principal Funds, Inc
1.497495%
487519

Global Institutional Holdings in Collegium Pharmaceutical

Funds
Holdings
iShares
11.88%
Vanguard
5.71%
Invesco
3.18%
SPDR
2.66%
Avantis
1.56%

Insights on Collegium Pharmaceutical

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 193.52M → 199.87M (in $), with an average increase of 3.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, United Therapeutics Corporation Common Stock has given 59.6% return, outperforming this stock by 84.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation Common Stock has given 119.1% return, outperforming this stock by 98.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 31.50M → -15.05M (in $), with an average decrease of 88.2% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, COLL stock has moved down by -21.8%

About Collegium Pharmaceutical

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone for the management of pain severe enough to require daily; Nucynta ER and Nucynta IR, which are extended-release and immediate-release oral formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. Collegium Pharmaceutical, Inc. was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. The company was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
OrganisationCollegium Pharmaceutical
Headquarters100 Technology Center Drive, Stoughton, MA, United States, 02072
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Vikram Karnani
E-voting on sharesClick here to vote

Key Management of Collegium Pharmaceutical

Name

Title

Mr. Scott Sudduth

EVP & Head of Technical Operations

Mr. Vikram Karnani

CEO, President & Director

Ms. Colleen Tupper

Executive VP & CFO

Mr. David Dieter

Executive VP, General Counsel & Corporate Secretary

Dr. Thomas B. Smith FAAFP, M.D.

Executive VP & Chief Medical Officer

Ms. Jane Gonnerman

Executive Vice President of Strategy & Corporate Development

Mr. Ian Karp M.B.A.

Head of Investor Relations

Ms. Jessica Cotrone

Senior Vice President of Communications & Corporate Affairs

Mr. Dean J. Patras

Chief People Officer

FAQs

What is Collegium Pharmaceutical share price today?

Collegium Pharmaceutical share price today is $28.07 as on at the close of the market. Collegium Pharmaceutical share today touched a day high of $29.01 and a low of $27.87.

What is the 52 week high and 52 week low for Collegium Pharmaceutical share?

Collegium Pharmaceutical share touched a 52 week high of $50.79 on and a 52 week low of $25.47 on . Collegium Pharmaceutical stock price today i.e. is closed at $28.07,which is 44.73% down from its 52 week high and 10.21% up from its 52 week low.

What is Collegium Pharmaceutical's market capitalisation today?

Collegium Pharmaceutical market capitalisation is $0.00T as on .

How to invest in Collegium Pharmaceutical Stock (COLL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Collegium Pharmaceutical on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Collegium Pharmaceutical Shares that will get you 0.0534 shares as per Collegium Pharmaceutical share price of $28.07 per share as on August 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy Collegium Pharmaceutical Stock (COLL) from India?

Indian investors can start investing in Collegium Pharmaceutical (COLL) shares with as little as ₹95.592 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.92 in Collegium Pharmaceutical stock (as per the Rupee-Dollar exchange rate as on ). Based on Collegium Pharmaceutical share’s latest price of $28.07 as on August 18, 2026 at 1:29 am IST, you will get 0.3563 shares of Collegium Pharmaceutical. Learn more about fractional shares .

What are the returns that Collegium Pharmaceutical has given to Indian investors in the last 5 years?

Collegium Pharmaceutical stock has given 37.57% share price returns and 28.34% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?